HCA Healthcare (NYSE:HCA) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

HCA Healthcare (NYSE:HCA) issued its earnings results on Friday. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03, Briefing.com reports. The business had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.84 EPS.

Here are the key takeaways from HCA Healthcare’s conference call:

• HCA said the expiration of enhanced premium tax credits drove a bigger-than-expected payer mix shift, with exchange admissions down 15% and most of those patients moving almost one-for-one to uninsured.
• The company reported 11% diluted EPS growth in both the quarter and year to date, even as adjusted EBITDA was pressured by coverage losses and higher uncompensated care.
• Underlying demand remained solid, with ER visits up 3.6% and insured volumes excluding exchanges increasing, while HCA expects long-term demand growth of 2%-3% supported by population trends.
• Management highlighted over $7 billion of capital expenditures and continued network expansion, including new beds and outpatient facilities, as part of a strategy to grow capacity and market share.
• HCA updated full-year guidance to Adjusted EBITDA of $15.4 billion-$16.1 billion and said its resiliency program, cost discipline, and Medicaid supplemental payments should help offset some of the exchange headwind in the back half of 2026.

HCA Healthcare Price Performance

Shares of HCA stock traded up $8.32 during trading hours on Friday, reaching $384.82. The company had a trading volume of 940,743 shares, compared to its average volume of 1,327,437. The business has a fifty day simple moving average of $387.76 and a 200-day simple moving average of $454.23. HCA Healthcare has a 12 month low of $330.00 and a 12 month high of $556.52. The company has a market cap of $85.37 billion, a price-to-earnings ratio of 13.25, a price-to-earnings-growth ratio of 1.25 and a beta of 1.12.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA reported Q2 2026 EPS of $7.59, edging past estimates, while revenue rose 8.7% year over year to $20.23 billion, also ahead of expectations. The beat was supported by strong admissions growth and generally healthy operating performance. Article Title
• Positive Sentiment: The company’s earnings release said results were consistent with its earlier preview and included updated guidance and key assumptions, which may reassure investors that the quarter was not a one-time surprise. Article Title
• Neutral Sentiment: Several articles focus on the same earnings release and analysis of key metrics, reinforcing that the main catalyst for the stock is the better-than-expected quarter rather than a new separate event. Article Title
• Neutral Sentiment: There were also multiple law-firm investigation notices related to HCA, but they appear to be routine securities-litigation outreach rather than confirmed new findings. These headlines could create some noise, but they are not the primary driver of today’s move. Article Title
• Negative Sentiment: The legal-investigation headlines could be a slight overhang if investors worry about potential litigation risk, though they are secondary to the earnings beat. Article Title

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. Brighton Jones LLC purchased a new position in HCA Healthcare in the fourth quarter worth $1,021,000. NewEdge Advisors LLC boosted its holdings in shares of HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after buying an additional 409 shares during the last quarter. Sivia Capital Partners LLC raised its position in HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after acquiring an additional 33 shares during the period. Jump Financial LLC bought a new position in shares of HCA Healthcare during the 2nd quarter valued at approximately $2,073,000. Finally, Sei Investments Co. lifted its position in shares of HCA Healthcare by 56.3% during the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after buying an additional 49,214 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Jefferies Financial Group set a $450.00 price objective on shares of HCA Healthcare in a report on Tuesday, July 14th. JPMorgan Chase & Co. dropped their price target on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research note on Tuesday, May 19th. Cantor Fitzgerald cut their price objective on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 7th. Truist Financial set a $413.00 price target on shares of HCA Healthcare in a report on Thursday, June 4th. Finally, TD Cowen lowered their target price on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Fourteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $483.45.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.